• Теги
    • избранные теги
    • Компании2230
      • Показать ещё
      Разное499
      • Показать ещё
      Страны / Регионы457
      • Показать ещё
      Международные организации39
      • Показать ещё
      Показатели26
      • Показать ещё
      Люди55
      • Показать ещё
      Формат23
      Издания17
      • Показать ещё
15 сентября, 19:49

Директором «Ак Барс Недвижимости» назначена Елена Стрюкова

Новым директором «Ак Барс Недвижимости» назначена Елена Стрюкова, полномочный представитель российской гильдии управляющих и девелоперов в РТ. Об этом компания сообщила на своей официальной странице «ВКонтакте».

Выбор редакции
15 сентября, 17:55

Oncology Space in Focus this Week on ESMO Presentations

There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca's lung cancer study data was positive and so was Bristol-Myers's melanoma candidate.

15 сентября, 17:55

Oncology Space in Focus this Week on ESMO Presentations

  • 0

There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca's lung cancer study data was positive and so was Bristol-Myers's melanoma candidate.

15 сентября, 00:31

AstraZeneca заплатит за госзакупки

Компания AstraZeneca может первой из фармацевтических компаний подписать специальный инвестиционный контракт с государством, сообщил министр промышленности и торговли Денис Мантуров (его цитирует «Фармвестник»). В ближайшее время запланировано подписание специального инвестконтракта с AstraZeneca на 10 лет, подтвердил представитель Минпромторга.

15 сентября, 00:31

AstraZeneca может стать первой фармкомпанией, подписавшей специальный инвестконтракт

Компания AstraZeneca может первой из фармацевтических компаний подписать специальный инвестиционный контракт с государством, сообщил министр промышленности и торговли Денис Мантуров (его цитирует «Фармвестник»). В ближайшее время запланировано подписание специального инвестконтракта с AstraZeneca на 10 лет, подтвердил представитель Минпромторга.

14 сентября, 18:12

AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs

AstraZeneca (AZN) recently sold its remaining rights to its anaesthetics medicines to Aspen Group for an upfront consideration of $555 million.

Выбор редакции
14 сентября, 10:30

AstraZeneca boosted by drug trial win for tough-to-treat type 1 diabetes patients

AstraZeneca has revealed positive trial data for a drug that helps lower weight and insulin dosing for type 1 diabetes sufferers, the tough-to-treat lifelong blood sugar disorder. The FTSE 100 firm’s drug Farxiga is already approved in the US for use in type 2 diabetes sufferers and racked up $457m (£346m) of sales in the first half of the year, up 22pc on the previous year, putting it on track for blockbuster earnings. It is not yet approved to treat the more severe type 1 condition. The initial readout from AstraZeneca’s so-called Depict phase three study found type 1 patients who took Farxiga alongside insulin were better able to control their blood sugar levels. They also benefitted from weight loss and fewer insulin doses, with glucose levels remaining at a healthy level for at least two hours longer on average between doses. AstraZeneca 1-year share price The data, released at a medical conference in Lisbon, provides a further boost for the drugmaker after a tough summer, with a negative readout on a lung cancer trial wiping £10bn from its market value. Last week AstraZeneca also unveiled full data for two successful trials for separate, less common types of lung cancer. Millions of people worldwide have type 1 diabetes, including around 400,000 in the UK, with few treatment options available. Unlike in type 2 diabetes, where there is insulin deficiency, with type 1 the person’s pancreas doesn’t produce any insulin, leading to more severe symptoms including severe weight loss and fatigue. Paresh Dandona, lead investigator on the trial and professor of medicine at the University of Buffalo, said: “There remains a high unmet medical need in helping treat the millions of patients living with type 1 diabetes while managing the complications associated with the disease. “It is critical that we continue to advance clinical research with newer and novel therapies.” Separately AstraZeneca announced today it had sold the rights to a range of anaesthetic medicines to South African pharmaceuticals group Aspen for $555m. The deal is part of a drive to sell-off non-core products to focus on its three core therapy areas of cancer, respiratory and metabolic conditions. How to connect with us | Telegraph Business on social media

13 сентября, 00:36

Bristol-Myers Reports Positive Results from Melanoma Study

Bristol-Myers Squibb Company (BMY) announced encouraging results from a phase III study, CheckMate -238, on Opdivo.

Выбор редакции
13 сентября, 00:21

Лекарства не держат марку // Фармкомпании предлагают отложить введение системы обязательных меток

Члены Ассоциации российских фармацевтических производителей (АРФП), среди которых Stada, AstraZeneca, Bayer, предлагают перенести срок перехода на тотальную маркировку лекарств с 2019 на 2021 год. Они опасаются, что 80% производителей не успеют к назначенному сроку установить необходимое оборудование и непромаркированные препараты могут оказаться в нелегальном обороте. У участников рынка еще есть возможность повлиять на ситуацию, поскольку соответствующий законопроект пока не принят.

12 сентября, 18:25

AstraZeneca's Asthma Candidate Shows Promising Results

AstraZeneca's asthma candidate, benralizumab, showed promising results in patients who experience more frequent exacerbations despite being on standard-of-care medicines.

Выбор редакции
12 сентября, 11:14

AstraZeneca начнет выпуск препаратов от рака легких на заводе в Калужской области

Шведско-британская AstraZeneca начнет на своем заводе в индустриальном парке "Ворсино" Калужской области производство онкотарентного препарата для лечения рака легких

11 сентября, 22:17

AstraZeneca's Lung Cancer Study Data Promising, Shares Spike

AstraZeneca, (AZN) releases data from a late-stage study on Imfinzi which showed that the new cancer drug led to superior progression-free survival to standard of care in lung cancer patients.

Выбор редакции
11 сентября, 20:00

Irma, AstraZeneca gives FTSE a leg-up

By Kit Rees LONDON (Reuters) - Britain's top share index closed higher on Monday, boosted by financial stocks which surfed an insurance rally across Europe and the United States as estimates of the cost ...

11 сентября, 19:01

Drugs help fight cancer at ‘an earlier stage’

Cancer doctors are widening the net for immunotherapy, a new class of drugs that enlist the body’s defenses in the fight against tumors.

Выбор редакции
11 сентября, 18:21

Generic drug giant picks new chief after search hiccups

Teva appoints Kare Schultz having been previously linked with AstraZeneca’s chief

Выбор редакции
11 сентября, 17:21

AstraZeneca, Merck and Inctye show cancer treatment advances

Shares gain on back of positive data presented at Madrid oncology conference

11 сентября, 13:30

Основные фондовые индексы Европы растут

Европейские фондовые индексы выросли в понедельник утром, чему способствовали успехи на торгах в Азии, в то время как инвесторы продолжали следить за экономическими последствиями урагана Ирма. Общеевропейский индекс Stoxx 600 вырос на 0,94 процента во время утренних сделок, причем почти все сектора и крупные биржи были на положительной территории. Страховые акции возглавили рост в понедельник, увеличившись более чем на 2 процента, после того как прогнозируемые застрахованные убытки в США, полученные в результате урагана Ирма, сократились до диапазона $ 20 - 40 миллиардов. Среди лучших в Европе страховых компаний были Hannover Re, Swiss RE и Munich Re, которые выросли более чем на 4 процента. Между тем, британский Beazley взлетел до вершины индекса, поднявшись более чем на 5,5 процента. Розничные акции также выросли более чем на 1 процент в утренних сделках. Этот сектор был поддержан шведским розничным торговцем H & M после того, как группа получила повышение рейтинга от Credit Suisse. Банк повысил рейтинг акций компании на две ступени, до «выше рынка» от «ниже рынка» в понедельник. Акции компании превысили 3 процента. Датская фармацевтическая компания Lundbeck упала до нижней границы индекса в понедельник. Генеральный директор группы Каре Шульц отказался от своей должности в группе и решил присоединиться к израильской фармацевтической компании «Тева». Акции Lundbeck упали на 12 процентов на новостях. В другом месте фармацевтический супертяжеловес Astrazeneca сообщил, что два из его препаратов для лечения рака легких показали впечатляющие клинические результаты в субботу. Его акции выросли более чем на 2 процента в понедельник утром. Ураган Ирма ослабел до шторма категории 1, и, согласно последнему обновлению Национального центра ураганов, он станет тропическим штормом позже в понедельник. Шторм в настоящее время сосредоточен примерно в 60 милях к северу от Тампы, штат Флорида. На текущий момент FTSE 7427.91 50.31 0.68% DAX 12440.07 136.09 1.11% CAC 5175.40 61.91 1.21% Информационно-аналитический отдел TeleTradeИсточник: FxTeam

11 сентября, 11:12

Global relief rally continues on US stock markets; insurers jump on receding Hurricane Irma fears

FTSE 100 rebounds into positive territory following gloomy week of trading last week; AstraZeneca jumps to the top of the blue-chip leaderboard on positive drug trial results Pound holds six-week high against the dollar; trading flat at $1.3192 ahead of Repeal Bill ABF dips despite raising its full-year outlook as its Primark business continues to enjoy strong growth; Randgold Resources and Fresnillo drop as rising risk appetite pulls down gold prices Lloyd's of London insurers rise as payout fears recede; cost from Hurricane Irma expected to be less than initially thought 3:14PM Warning: Brexit could land business with £4bn a year customs bill without transitional deal Trucks going through ports could stack up as customs controls are reintroduced British businesses that export to Europe could collectively face a multi-billion pound Brexit bill if  the UK and the European Union are unable to agree a transitional customs deal, a think-tank has warned. The Institute for Government (IFG) says that should the UK leave the EU without a negotiated agreement on customs, controls at borders "could be introduced overnight”. It calculates that there are 180,000 business - most of them SMEs - trading with Europe who will need to make customs declarations following Brexit, landing them with a combined bill of at least £4bn in the first year alone. Read Alan Tovey's full report here 2:56PM Dow Jones rallies into positive territory; Petra Diamonds plummets on Tanzania dispute The Dow Jones has rallied into positive territory today The global relief rally has extended into the US session with the Dow Jones opening 0.8pc higher as Hurricane Irma and North Korea fears subside. Travelers Companies, an insurance firm, has followed its peers in Europe and jumped over 5pc on the index as concerns over the impact of Hurricane Irma on the sector fade. Meanwhile back in Europe, the FTSE 100 has given up some of its morning gains with the handful of stocks that started the day in the red steadily growing. On the FTSE 250, Tanzania's latest hostilities with foreign mining companies have pulled down Petra Diamonds and Acacia Mining. Petra Diamonds shares have shed nearly 9pc of their value today after the Government seized a package of diamonds it said had been undervalued, leading to the company suspending operations at its mine there. 2:26PM Google appeals against record monopoly abuse fine The company was fined £2.2bn in June Google has launched an appeal against the European Commission's record £2.2bn monopoly abuse fine, it has been confirmed in the last half hour. As reported in The Sunday Telegraph, the company will extend the seven-year dispute between the company and the EU over allegations that it exploited the dominance of its search engine to push its own online shopping service. Q&A | Why is Google being fined? 2:11PM Pink flamingos boost Primark sales and ABF forecasts Shoppers also flocked to Primark stores for pink flamingos Shoppers flocked to Primark stores over the summer to snap up pink flamingo pool inflatables alongside their holiday wardrobe essentials, helping to boost parent group Associated British Food's full-year forecasts. John Bason, ABF finance boss, said that the huge demand for its ornithological-inspired inflatables was one of the suprise big-sellers which helped the high street retailer smash its sales predictions for the summer and avoid heavy discounting.  The trend for over the top swimming accessories has been driven by celebrities such as Taylor Swift and Kourtney Kardashian and fuelled by social media posers. During the summer Primark was selling £9 flamingo inflatables as well as blow-up unicorns and £1 doughtnut-shaped floating cupholders. Shares fell by 3pc this morning following the results. Read Ashley Armstrong's full report here ABF 1:49PM Economics preview: Trio of UK macro releases will dominate sentiment this week The Bank of England's MPC is expected to vote to leave rates unchanged at 0.25pc With no economics data for the markets to pore over today, let's have a quick look at the key trio of macro releases due later this week. Tomorrow inflation is expected to pick-up to 2.8pc, tightening the squeeze on households, while on Wednesday wage growth figures will show whether the gap between pay and rising prices in the UK has continued to widen again. A day later we'll get the latest interest rate decision from the Bank of England on a 'Super Thursday' that might not quite live up to its name. The markets are currently pricing in just a 5.1pc chance of a hike in Thursday's meeting with patchy economics figures and cooling inflation in the last few months diminishing the clamour for a rise. Are the markets underestimating the chance of a hike? ETX analyst Neil Wilson gave this prediction for Thursday's decision: "The MPC is all but certain to leave everything well alone, with interest rates to be held at 0.25% and the size of the asset purchase programme unaltered at £435bn. At present there are simply too many unknowns for the Bank to hike to rates. However policymakers are likely to continue to stress that their tolerance for above- target inflation is not unlimited and that the market is underestimating their willingness to act. "The vote is expected to be 7-2 in favour of leaving rates unchanged, with confirmed hawks Ian McCafferty and Michael Saunders likely to vote for a hike. Andy Haldane is probably the only real unknown but the chief economist is, on balance, just seen voting for the status quo."  1:19PM Facebook hit with €1.2m fine in Spain for breaking privacy laws The company is also under investigation in France, Germany and the Netherlands Facebook has been hit with a €1.2m (£1.1m) fine in Spain after the country's data watchdog found it broke privacy laws. The social network breached laws designed to protect citizens' information and privacy on three occasions, according to the Spanish authorities. The regulator found Facebook had failed to inform users how their data would be used as it hoovered up the details of millions of people in Spain. It said Facebook had failed to educate users on how their personal information - including ideology, sex, religious beliefs, personal interests and browsing habits - would be used for advertising. It added that Facebook had illegally tracked visitors to its pages who had not signed up to the social network using cookies. Read Cara McGoogan's full report here 12:43PM Lunchtime update: Risk appetite rises on the markets as North Korea tensions fade The costs of Hurricane Irma are expected to be less than initially thought North Korea's nuclear no-show over the weekend has lifted the mood on global stock markets this morning with the FTSE 100 rebounding back into positive territory. The pound rising to over $1.32 against the dollar ahead of a big week of UK economics data couldn't dampen spirits in London with insurers enjoying a relief rally as the fears of eye-watering costs from Hurricane Irma recede. ABF has retreated despite its Primark business enjoying strong sales growth while pharma giant AstraZeneca has jumped towards the top of the blue-chip index after positive lung cancer drug trials. Accendo Markets analyst Mike Van Dulken said this on today's play: "Traders have started the new week hungry for risk, pushing equities and base metals higher on reduced concerns about North Korea and Hurricane Irma (although both very much still in play) and supportive China inflation data. As usual, bullishness has proved detrimental to safe havens like Gold, Bonds and the Yen & Swiss Franc. "The German DAX outperforms thank to a EUR/USD pullback from Friday's highs benefiting the index in general while Insurers/financials welcome a, thus far, less destructive Floridian path for Hurricane Irma. The UK FTSE 100 is higher, albeit to a lesser degree, and despite a strong GBP ahead of Thursday’s BoE policy update." 12:24PM Tesco deducted £3.4m from charity plastic bag sales last year for admin costs Tesco sells more plastic bags than any other UK supermarket Tesco has been criticised for deducting millions of pounds from charity donations generated by the plastic bag tax in order to cover "administration costs". New government data shows that Britain's biggest supermarket sold 637m carrier bags in the year to March 2017, raising almost £32m in proceeds. But it withdrew £3.4m of this to cover the “cost of administering donations”, equivalent to more than 10pc of the total. The government figures show that no other major supermarket – including Asda, Sainsbury's, Morrisons and Waitrose – made any such deductions from plastic bag sales, and instead passed on all proceeds to charities. Read Sophie Christie's full report here 12:08PM Pound pushes over $1.32 ahead of hectic week of economics data Brexit Secretary David Davis has said that voting against the Repeal Bill would lead to a "chaotic" Brexit The pound has risen to a six-week high against the dollar, just over $1.32, ahead of a crucial week of economics data for the UK. Key inflation data is due tomorrow and on Wednesday we'll find out if wage growth has eased the pressure on households suffering from rising prices. Stronger economics figures last week have helped to lift the pound from its August lows, according to MUFG currency analyst Lee Hardman. He said: "With growth in manufacturing output expanding solidly by 0.5% in July, there is some encouragement that the sharp improvement in business confidence driven in part by the weaker pound and stronger global growth is beginning to feed through into  hard economic data. "At this stage we still believe it is best to treat the recent improvement in UK economic data flow with caution. Plenty of tests are coming up for the currency, however. In addition to the inflation and wage data, we have Bank of England 'Super Thursday' later this week and the Repeal Bill vote in parliament later today. 11:40AM North Korea 'an unlikely source of bullish sentiment' on stock markets The UN Security Council will vote today on sanctions for North Korea On the markets no North Korea news is good news. The rogue state's unexpectedly quiet weekend has prompted a strong rally on European stock markets this morning with the FTSE 100 now 0.7pc up and the DAX in Germany enjoying a 1.1pc rise. Investors were worried that the country's founding day on Saturday would be marked by another show of military muscle but it passed uneventfully. The lack of any major economics releases means that Kim Jong-Un is the "unlikely source of bullish sentiment" on global stock markets, according to IG market analyst Joshua Mahony. He commented: "Markets have started the week in a positive fashion, with risk assets firmly in the driving seat at the expense of the commonly perceived havens such as gold, treasuries, and the yen. "The FTSE has utilised this morning’s bullish sentiment to build on the strong end to last week, rising to levels seen almost a week ago. It has been notable that the FTSE has held up well despite a surging pound and a significant degree of geopolitical risk associated with North Korea." With the UN Security Council due to meet later today over whether to implement oil sanctions on the rogue state, a renewed flare-up in tensions seems only round the corner, however. Asian equity markets have rebounded overnight as North Korea’s founding day passed without a missile test.— Arjun K Lakhanpal (@Arjun_lakhanpal) September 11, 2017 11:10AM Could Hurricane Irma actually benefit US GDP? Downtown Miami was flooded by Hurricane Irma While Hurricane Irma will undoubtedly have a short-term impact on the economy in Florida, the rebuilding process could actually support growth figures in the future, some analysts have suggested this morning. The hurricane season will pull down third quarter GDP figures but a boost to the US construction industry will lift GDP figures in the final quarter of 2017 and first quarter of next year, according to head of investment at Interactive Investor Rebecca O'Keeffe. She said:  "Rebuilding and reconstruction are likely to be a central theme over coming weeks with the DIY and construction industries likely to be beneficiaries. Demand for new automobiles could be affected substantially by their growing susceptibility to damage from floodwater. "Oil and oil product markets remain volatile as the knock-on effects of both Harvey and Irma may affect demand and supply for some time to come.  Florida is also a key supplier of agricultural produce to the US and wider market, not least orange-juice." 10:47AM Offshore wind to power £17.5bn investment boom as costs halve Offshore wind costs have halved in the last five years The UK’s offshore wind sector could power a £17.5bn investment inthe UK economy over the next four years after faster than expected cost-cutting slashed subsidies for the technology by half. The Government’s latest auction for support contracts, released this morning, shows that offshore wind costs have halved in the last five years to under £58 for every megawatt-hour of electricity produced, even lower than the estimates given by experts in the run-up to the results. The lower costs mean more wind farms will be able to apply for the £294m funding pot, bringing an investment surge of £17.5bn into the UK. The boom is even greater than the £11bn predicted by Renewable UK as recently as last week. “We knew today’s results would be impressive, but these are astounding," said Hugh McNeal, chief executive of Renewable UK. "Record-breaking cost reductions like the ones achieved by offshore wind are unprecedented for large energy infrastructure." Read Jillian Ambrose's full report here 10:39AM Insurers rebound as Hurricane Irma payout fears recede Flooded streets in Havana which was battered by Hurricane Irma Hopes that the damage caused by Hurricane Irma will be less severe than expected has lifted the Lloyd's of London insurers heavily exposed to events in the US this morning. European insurers retreated last week on fears of huge payouts in the aftermath of the two hurricanes that have left a trail of destruction in the Caribbean and southern US. The damages could, however, come in at less than $50bn compared to a previous estimate of around $192bn, according to LCG analyst Ipek Ozkardeskaya. On the FTSE 250, Lancashire Holdings and Beazley have jumped 7.5pc and 5.7pc, respectively, while the Stoxx 600 insurance index, which tracks the performance of all the large insurance companies in Europe, has enjoyed its best day since April, rising 2pc. 10:10AM AstraZeneca jumps to the top of FTSE 100 on positive drug trials AstraZeneca chief executive Pascal Soriot had been rumoured to be leaving for Israeli rival Teva Pharma giant AstraZeneca leads the blue-chip stocks in London this morning after reporting positive results from two phase III lung cancer drug trials. The Flaura Tagrisso and Pacific trials data beat "already high expectations", commented Liberum analyst Roger Franklin. He said: "The Flaura Tagrisso data delivered almost exactly what was expected at progression-free survival but with the kicker of positive early overall survival trends. More importantly, in Pacific, the magnitude of the progression-free survival benefit over placebo was truly impressive " Rebound of #ASTRAZeneca from end-July 5mth lows continues, +2.4%. Drug that saw setback in advanced cancer shows promising stage 3 data ^KO— City Index (@CityIndex) September 11, 2017 AstraZeneca's shares crashed 15pc in July following poor results in its MYSTIC lung cancer drug trial. However, it has slowly clawed back value since and today's 1.9pc rise leaves it just 4.6pc short of its share price just before the MYSTIC trials disappointed. Its chief executive Pascal Soriot was rumoured to be on the verge of jumping ship to rival Teva earlier this summer but the Israeli company finally filled its vacancy this morning with Kaare Schultz  from H. Lundbeck A/S. 9:48AM Carillion confirms departure of finance boss amid string of management changes Carillion is reeling from a chaotic few months Troubled support services firm Carillion has confirmed the departure of its finance director as it announces a string of changes to its management team. It was reported over the weekend that finance boss Zafar Khan was due to step down from the business, which has lost almost £800m from its market capitalisation in recent weeks. In a statement to the stock market, Carillion said Mr Khan had left the company with immediate effect. He has been replaced by Emma Mercer, who has previously served as finance director of Carillion's UK construction business, as well as chief financial officer and senior vice president of Carillion Canada. Carillion shares have fallen 4.3pc this morning. Read Sam Dean's full report here Carillion 9:25AM ABF dips despite lifting its outlook on strong Primark performance Primark's strong performance has lifted owner ABF's guidance for the year Associated British Foods is the biggest laggard on the FTSE 100 this morning, dipping 2.1pc, despite lifting its full-year guidance as sales and margins improve at its key Primark business. ABF said that the discount fashion retailer will enjoy a 13pc rise in sales on a constant currency basis despite the bleak consumer backdrop. The company is "well ahead of last year", according to Hargreaves Lansdown analyst George Salmon. He added on what the results mean for the rest of the struggling high street: "The UK has been singled out as performing particularly strongly, which would normally have positive read-across for the rest of the clothing sector. However, this probably isn’t the case this time. "We feel Primark’s good domestic performance is more a sign the UK consumer is tightening the purse strings and moving down the value chain as inflation outstrips wage growth." 9:12AM North Korea nuclear no-show lifts sentiment on the markets Rising risk appetite has been helped by North Korea's nuclear no-show North Korea's nuclear no-show over the weekend has lifted the mood on European stock markets this morning with all the major indices rebounding after a gloomy week of trading last week. There were fears that the rogue state would conduct its latest round of tests on Saturday, the nation's founding day, with tensions rising on the UN Security Council over whether to ban the country's oil imports.  Gold has been pulled off its 13-week high, bringing down shares in FTSE 100 precious metal miners Fresnillo and Randgold Resources, while safe haven the Japanese yen is the biggest laggard on the currency markets, slipping 0.5pc against the dollar. The mood has also been helped by Hurricane Irma's strength waning, according to Accendo Markets analyst Mike Van Dulken. He said: "This helpful combo has seen a return of risk appetite and corresponding fall in demand for safe havens. Equities and base metals thus called higher at the expense of Gold, Silver, bonds, the Japanese Yen and Swiss Franc." 8:38AM Agenda: Rising risk appetite pulls up European stock markets Primark owner ABF has retreated into the red despite lifting its full-year outlook Welcome to our live markets coverage. Rising risk appetite on the markets has lifted the FTSE 100 back into positive territory this morning with pharma giant AstraZeneca leading the index after jumping just under 3pc on successful lung cancer drug trial results. Four negative sessions last week pulled the UK's blue-chip index lower but the mood on European stock markets has improved over the weekend with the DAX and CAC 40 enjoying strong rebounds. Gold's retreat this morning as risk-on mood returns to the markets has wounded precious metal miners Randgold Resources and Fresnillo while ABF has nudged down despite raising its full-year outlook thanks to strong results in its Primark business. Asia stocks start the week higher in risk-on mood w/ Yen weaker, Treasury ylds rising as Irma weakens & UN to vote on oil embargo of N Korea pic.twitter.com/tZAHHjmUAB— Holger Zschaepitz (@Schuldensuehner) September 11, 2017 The economics calendar has a very light look to it but any wobbles in passing the Repeal Bill in parliament later today could stoke some movement on currency markets. With inflation and wage growth data due in the coming days, you couldn't blame traders for sitting on their hands until they get hold of this week's highlight economics figures. This morning, the pound has held onto its six-week high against the dollar from Friday, trading flat at $1.3190. Interim results: Restore, Luceco, Deltex Medical Group, EKF Diagnostics Holdings, Cloudcall Group, John Laing Infrastructure Fund, XLMedia, Pennant International Group, Crossrider Full-year results: Abcam, K3 Capital Group, 1pm Trading statement: Associated British Foods AGM: Real Estate Credit Investments, CH Bailey, Empyrean Energy

Выбор редакции
11 сентября, 10:12

AstraZeneca shares rise 2.5% after positive results in 2 lung cancer trials

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.